Vision- and Health-Related Quality of Life in Patients With Behçet Uveitis | Ophthalmology | JAMA Ophthalmology | JAMA Network
[Skip to Navigation]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
Behçet  H  Über rezidivierende aphthose, durch ein Virus verursachte Geschwüre am Mund, am Auge und an den Genitalien.  Dermatol Wochenschr 1937;1051152- 1157Google Scholar
Tugal-Tutkun  IOnal  SAltan-Yaycioglu  RHuseyin Altunbas  HUrgancioglu  M Uveitis in Behçet disease: an analysis of 880 patients.  Am J Ophthalmol 2004;138 (3) 373- 380PubMedGoogle Scholar
Krause  IMader  RSulkes  J  et al.  Behçet's disease in Israel: the influence of ethnic origin on disease expression and severity.  J Rheumatol 2001;28 (5) 1033- 1036PubMedGoogle Scholar
Jabs  DANussenblatt  RBRosenbaum  JTStandardization of Uveitis Nomenclature (SUN) Working Group, Standardization of uveitis nomenclature for reporting clinical data: results of the First International Workshop.  Am J Ophthalmol 2005;140 (3) 509- 516PubMedGoogle Scholar
Jabs  DARosenbaum  JTFoster  CS  et al.  Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel.  Am J Ophthalmol 2000;130 (4) 492- 513PubMedGoogle Scholar
Harper  SLChorich  LJFoster  CS Principles of diagnosis and therapy. Foster  CSVitale  AT Diagnosis and Treatment of Uveitis. Philadelphia, PA WB Saunders 2002;79- 103Google Scholar
Mangione  CMLee  PPGutierrez  PRSpritzer  KBerry  SHays  RDNational Eye Institute Visual Function Questionnaire Field Test Investigators, Development of the 25-item National Eye Institute Visual Function Questionnaire.  Arch Ophthalmol 2001;119 (7) 1050- 1058PubMedGoogle Scholar
Ware  JEKosinski  MKeller  S SF-36 Physical and Mental Health Summary Scales: A User Manual.  Boston, MA Medical Outcomes Trust1994;
Toprak  ABEser  EGuler  CBaser  FEMayali  H Cross-validation of the Turkish version of the 25-item National Eye Institute Visual Functioning Questionnaire (NEI-VFQ 25).  Ophthalmic Epidemiol 2005;12 (4) 259- 269PubMedGoogle Scholar
Pinar  R Reliability and construct validity of the SF-36 in Turkish cancer patients.  Qual Life Res 2005;14 (1) 259- 264PubMedGoogle Scholar
Schiffman  RMJacobsen  GWhitcup  SM Visual functioning and general health status in patients with uveitis.  Arch Ophthalmol 2001;119 (6) 841- 849PubMedGoogle Scholar
Toker  EOnal  SEraslan  MEyriparmak  M The Turkish version of the National Eye Institute Refractive Error Quality of Life Instrument: translation, validity and reliability.  Qual Life Res 2008;17 (10) 1269- 1276PubMedGoogle Scholar
Demiral  YErgor  GUnal  B  et al.  Normative data and discriminative properties of Short Form 36 (SF-36) in Turkish urban population.  BMC Public Health 2006;6247PubMeddoi:10.1186/1471-2458-6-247Google Scholar
Onal  SKazokoglu  HDireskeneli  HYavuz  S Low-dose interferon alfa-2a therapy in severe uveitis associated with Behçet disease.  Am J Ophthalmol 2009;147 (6) 1109- 1110PubMedGoogle Scholar
Onal  SKazokoglu  HKoç  A  et al.  Low dose and dose escalating therapy of interferon alfa-2a in the treatment of refractory and sight-threatening Behçet's uveitis.  Clin Exp Rheumatol 2009;27 (2) ((suppl 53)) S113- S114PubMedGoogle Scholar
Clinical Sciences
October 11, 2010

Vision- and Health-Related Quality of Life in Patients With Behçet Uveitis

Author Affiliations

Author Affiliations: Uveitis Service, Department of Ophthalmology (Drs Onal, Savar, and Kazokoglu), and Department of Family Medicine (Dr Akman), School of Medicine, Marmara University, Istanbul, Turkey.

Arch Ophthalmol. 2010;128(10):1265-1271. doi:10.1001/archophthalmol.2010.209

Objective  To investigate vision- and health-related quality of life in patients with Behçet disease.

Methods  Fifty-one consecutive patients with Behçet uveitis were enrolled in the study from January 1 through June 30, 2008. The National Eye Institute Visual Functioning Questionnaire (NEI-VFQ-25) and the 36-Item Short Form Health Survey (SF-36) were administered. Sociodemographic and clinical data were also collected. Main outcome measures were comparison of the NEI-VFQ-25 and SF-36 subscale item scores among subgroups and multivariate analysis of the NEI-VFQ-25 and SF-36 subscale item scores.

Results  Patients rated the general health subscale score of the NEI-VFQ-25 and all subscale item scores of the SF-36 lower than the NEI-VFQ-25 subscales related to vision. The NEI-VFQ-25 subscale item scores showed significant differences with respect to age, educational level, Behçet uveitis activity and severity, and visual acuity in the better and worse eyes. The SF-36 subscale item scores revealed significant differences according to sex, educational level, and the systemic treatment used. In the best model of linear regression, independent variables accounted for 57.0% of the variance in the NEI-VFQ-25 subscale item (color vision subscale; adjusted R2 = 0.57, P < .001) and for only 23.0% of the variance in the SF-36 subscale item score (role limitation owing to emotional problems subscale; adjusted R2 = 0.23, P = .004).

Conclusions  General health is more affected than visual functioning in patients with Behçet uveitis. Sociodemographic and clinical variables had a significant effect on vision- and health-related quality of life. Multivariate analysis of the NEI-VFQ-25 and SF-36 subscales revealed that each subscale item score is affected by additional factor(s) other than those analyzed here.